Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,380 | 14,720 | 6,440 | 4,500 | 0 |
| Marketable Securities | 18,160 | 40,270 | 32,920 | 14,730 | 0 |
| Receivables | 760 | 890 | 260 | 830 | 0 |
| Other current assets | 320 | 310 | 320 | 420 | 0 |
| TOTAL | $24,620 | $56,190 | $39,940 | $20,480 | $0 |
| Non-Current Assets | |||||
| PPE Net | 680 | 1,420 | 1,710 | 1,740 | 0 |
| TOTAL | $680 | $1,420 | $1,710 | $1,740 | $0 |
| Total Assets | $25,300 | $57,610 | $41,660 | $22,230 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,430 | 9,040 | 6,160 | 2,640 | 0 |
| Accrued Expenses | 10 | 150 | 0 | 0 | 0 |
| Other current liabilities | 660 | 680 | 0 | 0 | 0 |
| TOTAL | $6,220 | $10,030 | $6,290 | $2,770 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $4,950 | $5,830 | $140 | $140 | $0 |
| Total Liabilities | $11,170 | $15,870 | $6,440 | $2,910 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 208,010 | 209,040 | 198,250 | 152,320 | 0 |
| Retained earnings | -206,470 | -187,410 | -169,050 | -139,020 | 0 |
| Other shareholders' equity | 6,960 | 14,360 | 20 | 20 | 0 |
| TOTAL | $14,130 | $41,740 | $35,210 | $19,310 | $0 |
| Total Liabilities And Equity | $25,300 | $57,610 | $41,650 | $22,220 | $0 |